{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:37:04Z","timestamp":1790127424259,"version":"4.0.1"},"reference-count":252,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12264-025-01505-1","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T19:40:27Z","timestamp":1758310827000},"page":"439-459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Role of Microglial Dysfunction in Parkinson\u2019s Disease: From Multifactorial Causes to Neurodegeneration"],"prefix":"10.1007","volume":"42","author":[{"given":"Yuxiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4199-3494","authenticated-orcid":false,"given":"Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3560-3392","authenticated-orcid":false,"given":"Jianshe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"1505_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-018-0457-8","volume":"561","author":"L Partridge","year":"2018","unstructured":"Partridge L, Deelen J, Eline Slagboom P. Facing up to the global challenges of ageing. Nature 2018, 561: 45\u201356.","journal-title":"Nature"},{"key":"1505_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.tig.2023.02.008","volume":"39","author":"KE Copley","year":"2023","unstructured":"Copley KE, Shorter J. Repetitive elements in aging and neurodegeneration. Trends Genet 2023, 39: 381\u2013400.","journal-title":"Trends Genet"},{"key":"1505_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102429","volume":"100","author":"N Vitorakis","year":"2024","unstructured":"Vitorakis N, Piperi C. Pivotal role of AGE-RAGE axis in brain aging with current interventions. Ageing Res Rev 2024, 100: 102429.","journal-title":"Ageing Res Rev"},{"key":"1505_CR4","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/molecules26082193","volume":"26","author":"P Cruz-Vicente","year":"2021","unstructured":"Cruz-Vicente P, Passarinha LA, Silvestre S, Gallardo E. Recent developments in new therapeutic agents against Alzheimer and Parkinson diseases: in-silico approaches. Molecules 2021, 26: 2193.","journal-title":"Molecules"},{"key":"1505_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00018-014-1774-1","volume":"72","author":"JN Le Grand","year":"2015","unstructured":"Le Grand JN, Gonzalez-Cano L, Pavlou MA, Schwamborn JC. Neural stem cells in Parkinson\u2019s disease: a role for neurogenesis defects in onset and progression. Cell Mol Life Sci 2015, 72: 773\u2013797.","journal-title":"Cell Mol Life Sci"},{"key":"1505_CR6","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/mds.28922","volume":"37","author":"H Murata","year":"2022","unstructured":"Murata H, Barnhill LM, Bronstein JM. Air pollution and the risk of Parkinson\u2019s disease: a review. Mov Disord 2022, 37: 894\u2013904.","journal-title":"Mov Disord"},{"key":"1505_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41531-020-00123-0","volume":"6","author":"D Sulzer","year":"2020","unstructured":"Sulzer D, Antonini A, Leta V, Nordvig A, Smeyne RJ, Goldman JE. COVID-19 and possible links with Parkinson\u2019s disease and Parkinsonism: from bench to bedside. NPJ Parkinsons Dis 2020, 6: 18.","journal-title":"NPJ Parkinsons Dis"},{"key":"1505_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 2023, 8: 267.","journal-title":"Signal Transduct Target Ther"},{"key":"1505_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","volume":"8","author":"X Li","year":"2023","unstructured":"Li X, Li C, Zhang W, Wang Y, Qian P, Huang H. Inflammation and aging: Signaling pathways and intervention therapies. Signal Transduct Target Ther 2023, 8: 239.","journal-title":"Signal Transduct Target Ther"},{"key":"1505_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00281-022-00944-6","volume":"44","author":"KS Heavener","year":"2022","unstructured":"Heavener KS, Bradshaw EM. The aging immune system in Alzheimer\u2019s and Parkinson\u2019s diseases. Semin Immunopathol 2022, 44: 649\u2013657.","journal-title":"Semin Immunopathol"},{"key":"1505_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102321","volume":"98","author":"K Singh","year":"2024","unstructured":"Singh K, Sethi P, Datta S, Chaudhary JS, Kumar S, Jain D, et al. Advances in gene therapy approaches targeting neuro-inflammation in neurodegenerative diseases. Ageing Res Rev 2024, 98: 102321.","journal-title":"Ageing Res Rev"},{"key":"1505_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.it.2020.02.002","volume":"41","author":"H Scheiblich","year":"2020","unstructured":"Scheiblich H, Trombly M, Ramirez A, Heneka MT. Neuroimmune connections in aging and neurodegenerative diseases. Trends Immunol 2020, 41: 300\u2013312.","journal-title":"Trends Immunol"},{"key":"1505_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell 2023, 186: 243\u2013278.","journal-title":"Cell"},{"key":"1505_CR14","doi-asserted-by":"crossref","unstructured":"Moqri M, Herzog C, Poganik JR, Consortium BOA, Justice J, Belsky DW, et al. Biomarkers of aging for the identification and evaluation of longevity interventions. Cell 2023;186: 3758\u20133775.","DOI":"10.1016\/j.cell.2023.08.003"},{"key":"1505_CR15","doi-asserted-by":"crossref","unstructured":"Aging Biomarker Consortium, Bao H, Cao J, Chen M, Chen M, Chen W, et al. Biomarkers of Aging. Sci China Life Sci 2023;66: 893\u20131066.","DOI":"10.1007\/s11427-023-2305-0"},{"key":"1505_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101934","volume":"88","author":"LC Behr","year":"2023","unstructured":"Behr LC, Simm A, Kluttig A, Grosskopf Gro\u00dfkopf A. 60 years of healthy aging: on definitions, biomarkers, scores and challenges. Ageing Res Rev 2023, 88: 101934.","journal-title":"Ageing Res Rev"},{"key":"1505_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"SC Cunnane","year":"2020","unstructured":"Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov 2020, 19: 609\u2013633.","journal-title":"Nat Rev Drug Discov"},{"key":"1505_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 2019, 15: 565\u2013581.","journal-title":"Nat Rev Neurol"},{"key":"1505_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1515\/revneuro-2020-0011","volume":"31","author":"T Schirinzi","year":"2020","unstructured":"Schirinzi T, Canevelli M, Suppa A, Bologna M, Marsili L. The continuum between neurodegeneration, brain plasticity, and movement: a critical appraisal. Rev Neurosci 2020, 31: 723\u2013742.","journal-title":"Rev Neurosci"},{"key":"1505_CR20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022974118","volume":"118","author":"F De Majo","year":"2021","unstructured":"De Majo F, Martens L, Hegenbarth JC, R\u00fchle F, Hamczyk MR, Nevado RM, et al. Genomic instability in the naturally and prematurely aged myocardium. Proc Natl Acad Sci U S A 2021, 118: e2022974118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1505_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tins.2021.12.002","volume":"45","author":"EM Rocha","year":"2022","unstructured":"Rocha EM, Keeney MT, Di Maio R, De Miranda BR, Greenamyre JT. LRRK2 and idiopathic Parkinson\u2019s disease. Trends Neurosci 2022, 45: 224\u2013236.","journal-title":"Trends Neurosci"},{"key":"1505_CR22","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.tibs.2022.06.009","volume":"47","author":"Y Park","year":"2022","unstructured":"Park Y, Liao J, Hoang QQ. Roc, the G-domain of the Parkinson\u2019s disease-associated protein LRRK2. Trends Biochem Sci 2022, 47: 1038\u20131047.","journal-title":"Trends Biochem Sci"},{"key":"1505_CR23","doi-asserted-by":"crossref","unstructured":"Pitz V, Makarious MB, Bandres-Ciga S, Iwaki H, Team 2R, Singleton AB, et al. Analysis of rare Parkinson\u2019s disease variants in millions of people. NPJ Parkinsons Dis 2024; 10: 11.","DOI":"10.21203\/rs.3.rs-2743857\/v1"},{"key":"1505_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1042\/BJ20140772","volume":"463","author":"DA Butterfield","year":"2014","unstructured":"Butterfield DA, Di Domenico F, Swomley AM, Head E, Perluigi M. Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down\u2019s syndrome and Alzheimer\u2019s disease brain. Biochem J 2014, 463: 177\u2013189.","journal-title":"Biochem J"},{"key":"1505_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","volume":"18","author":"MT Henrich","year":"2023","unstructured":"Henrich MT, Oertel WH, Surmeier DJ, Geibl FF. Mitochondrial dysfunction in Parkinson\u2019s disease\u2013a key disease hallmark with therapeutic potential. Mol Neurodegener 2023, 18: 83.","journal-title":"Mol Neurodegener"},{"key":"1505_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/cells14040276","volume":"14","author":"HM Yang","year":"2025","unstructured":"Yang HM. Mitochondrial dysfunction in neurodegenerative diseases. Cells 2025, 14: 276.","journal-title":"Cells"},{"key":"1505_CR27","doi-asserted-by":"crossref","unstructured":"Rossiello F, Jurk D, Passos JF, d\u2019Adda di Fagagna F. Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol 2022;24: 135\u2013147.","DOI":"10.1038\/s41556-022-00842-x"},{"key":"1505_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40035-021-00261-2","volume":"10","author":"HM Wilkins","year":"2021","unstructured":"Wilkins HM, Swerdlow RH. Mitochondrial links between brain aging and Alzheimer\u2019s disease. Transl Neurodegener 2021, 10: 33.","journal-title":"Transl Neurodegener"},{"key":"1505_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102734","volume":"63","author":"Y Han","year":"2023","unstructured":"Han Y, Liu D, Cheng Y, Ji Q, Liu M, Zhang B, et al. Maintenance of mitochondrial homeostasis for Alzheimer\u2019s disease: strategies and challenges. Redox Biol 2023, 63: 102734.","journal-title":"Redox Biol"},{"key":"1505_CR30","doi-asserted-by":"publisher","first-page":"1225578","DOI":"10.1155\/2022\/1225578","volume":"2022","author":"AJPO de Almeida","year":"2022","unstructured":"de Almeida AJPO, de Oliveira JCPL, da Silva Pontes LV, de Souza J\u00fanior JF, Gon\u00e7alves TAF, Dantas SH, et al. ROS: Basic concepts, sources, cellular signaling, and its implications in aging pathways. Oxid Med Cell Longev 2022, 2022: 1225578.","journal-title":"Oxid Med Cell Longev"},{"key":"1505_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.redox.2017.12.012","volume":"15","author":"B Kalyanaraman","year":"2018","unstructured":"Kalyanaraman B, Cheng G, Hardy M, Ouari O, Bennett B, Zielonka J. Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies. Redox Biol 2018, 15: 347\u2013362.","journal-title":"Redox Biol"},{"key":"1505_CR32","first-page":"1158","volume":"15","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhu Z, Wang X, Liu D, Liu X, Mi Z, et al. Comprehensive landscape of immune-based classifier related to early diagnosis and macrophage M1 in spinal cord injury. Aging (Albany NY) 2023, 15: 1158\u20131176.","journal-title":"Aging (Albany NY)"},{"key":"1505_CR33","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/biom14060670","volume":"14","author":"A Mukherjee","year":"2024","unstructured":"Mukherjee A, Ghosh KK, Chakrabortty S, Guly\u00e1s B, Padmanabhan P, Ball WB. Mitochondrial reactive oxygen species in infection and immunity. Biomolecules 2024, 14: 670.","journal-title":"Biomolecules"},{"key":"1505_CR34","doi-asserted-by":"publisher","first-page":"9912436","DOI":"10.1155\/2021\/9912436","volume":"2021","author":"GE Villalpando-Rodriguez","year":"2021","unstructured":"Villalpando-Rodriguez GE, Gibson SB. Reactive oxygen species (ROS) regulates different types of cell death by acting as a rheostat. Oxid Med Cell Longev 2021, 2021: 9912436.","journal-title":"Oxid Med Cell Longev"},{"key":"1505_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4103\/1673-5374.290889","volume":"16","author":"O Garaschuk","year":"2021","unstructured":"Garaschuk O. The role of NLRP3 inflammasome for microglial response to peripheral inflammation. Neural Regen Res 2021, 16: 294\u2013295.","journal-title":"Neural Regen Res"},{"key":"1505_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102157","volume":"47","author":"Y Pang","year":"2021","unstructured":"Pang Y, Wu D, Ma Y, Cao Y, Liu Q, Tang M, et al. Reactive oxygen species trigger NF-\u03baB-mediated NLRP3 inflammasome activation involvement in low-dose CdTe QDs exposure-induced hepatotoxicity. Redox Biol 2021, 47: 102157.","journal-title":"Redox Biol"},{"key":"1505_CR37","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s12264-023-01023-y","volume":"39","author":"QQ Han","year":"2023","unstructured":"Han QQ, Le W. NLRP3 inflammasome-mediated neuroinflammation and related mitochondrial impairment in Parkinson\u2019s disease. Neurosci Bull 2023, 39: 832\u2013844.","journal-title":"Neurosci Bull"},{"key":"1505_CR38","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","volume":"5","author":"A Picca","year":"2023","unstructured":"Picca A, Faitg J, Auwerx J, Ferrucci L, D\u2019Amico D. Mitophagy in human health, ageing and disease. Nat Metab 2023, 5: 2047\u20132061.","journal-title":"Nat Metab"},{"key":"1505_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101955","volume":"88","author":"Y Guo","year":"2023","unstructured":"Guo Y, Guan T, Shafiq K, Yu Q, Jiao X, Na D, et al. Mitochondrial dysfunction in aging. Ageing Res Rev 2023, 88: 101955.","journal-title":"Ageing Res Rev"},{"key":"1505_CR40","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1080\/15548627.2024.2322421","volume":"20","author":"JI Jim\u00e9nez-Loygorri","year":"2024","unstructured":"Jim\u00e9nez-Loygorri JI, Boya P. Aging STINGs: mitophagy at the crossroads of neuroinflammation. Autophagy 2024, 20: 1684\u20131686.","journal-title":"Autophagy"},{"key":"1505_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: Mechanisms and potential targets. Signal Transduct Target Ther 2023, 8: 333.","journal-title":"Signal Transduct Target Ther"},{"key":"1505_CR42","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang S, Long H, Hou L, Feng B, Ma Z, Wu Y, et al. The mitophagy pathway and its implications in human diseases. Signal Transduct Target Ther 2023, 8: 304.","journal-title":"Signal Transduct Target Ther"},{"key":"1505_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s11658-024-00572-y","volume":"29","author":"Y Lei","year":"2024","unstructured":"Lei Y, Gan M, Qiu Y, Chen Q, Wang X, Liao T, et al. The role of mitochondrial dynamics and mitophagy in skeletal muscle atrophy: from molecular mechanisms to therapeutic insights. Cell Mol Biol Lett 2024, 29: 59.","journal-title":"Cell Mol Biol Lett"},{"key":"1505_CR44","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41419-022-04906-6","volume":"13","author":"A Li","year":"2022","unstructured":"Li A, Gao M, Liu B, Qin Y, Chen L, Liu H, et al. Mitochondrial autophagy: Molecular mechanisms and implications for cardiovascular disease. Cell Death Dis 2022, 13: 444.","journal-title":"Cell Death Dis"},{"key":"1505_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41531-022-00402-y","volume":"8","author":"B Xiao","year":"2022","unstructured":"Xiao B, Kuruvilla J, Tan EK. Mitophagy and reactive oxygen species interplay in Parkinson\u2019s disease. NPJ Parkinsons Dis 2022, 8: 135.","journal-title":"NPJ Parkinsons Dis"},{"key":"1505_CR46","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1093\/brain\/awac405","volume":"145","author":"IG Ganley","year":"2022","unstructured":"Ganley IG. Strengthening the link between mitophagy and Parkinson\u2019s disease. Brain 2022, 145: 4154\u20134156.","journal-title":"Brain"},{"key":"1505_CR47","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ. Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy. Trends Biochem Sci 2021, 46: 329\u2013343.","journal-title":"Trends Biochem Sci"},{"key":"1505_CR48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41467-019-13781-3","volume":"11","author":"N Moskal","year":"2020","unstructured":"Moskal N, Riccio V, Bashkurov M, Taddese R, Datti A, Lewis PN, et al. ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway. Nat Commun 2020, 11: 88.","journal-title":"Nat Commun"},{"key":"1505_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624919","volume":"12","author":"LG de Oliveira","year":"2021","unstructured":"de Oliveira LG, Angelo YS, Iglesias AH, Peron JPS. Unraveling the link between mitochondrial dynamics and neuroinflammation. Front Immunol 2021, 12: 624919.","journal-title":"Front Immunol"},{"key":"1505_CR50","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/acel.12649","volume":"16","author":"JM Son","year":"2017","unstructured":"Son JM, Sarsour EH, Kakkerla Balaraju A, Fussell J, Kalen AL, Wagner BA, et al. Mitofusin 1 and optic atrophy 1 shift metabolism to mitochondrial respiration during aging. Aging Cell 2017, 16: 1136\u20131145.","journal-title":"Aging Cell"},{"key":"1505_CR51","doi-asserted-by":"publisher","first-page":"2059874","DOI":"10.1080\/2162402X.2022.2059874","volume":"11","author":"M Li","year":"2022","unstructured":"Li M, Hou X, Sai K, Wu L, Chen J, Zhang B, et al. Immune suppressive microenvironment in brain metastatic non-small cell lung cancer: Comprehensive immune microenvironment profiling of brain metastases versus paired primary lung tumors (GASTO 1060). Oncoimmunology 2022, 11: 2059874.","journal-title":"Oncoimmunology"},{"key":"1505_CR52","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.1038\/s41467-021-25859-y","volume":"12","author":"PK Brastianos","year":"2021","unstructured":"Brastianos PK, Strickland MR, Lee EQ, Wang N, Cohen JV, Chukwueke U, et al. Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis. Nat Commun 2021, 12: 5954.","journal-title":"Nat Commun"},{"key":"1505_CR53","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.7150\/thno.70756","volume":"12","author":"L Yang","year":"2022","unstructured":"Yang L, Wu C, Parker E, Li Y, Dong Y, Tucker L, et al. Non-invasive photobiomodulation treatment in an Alzheimer Disease-like transgenic rat model. Theranostics 2022, 12: 2205\u20132231.","journal-title":"Theranostics"},{"key":"1505_CR54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200230119","volume":"119","author":"W Liu","year":"2022","unstructured":"Liu W, Sun P, Xia L, He X, Xia Z, Huang Y, et al. A brain-enriched lncRNA shields cancer cells from immune-mediated killing for metastatic colonization in the brain. Proc Natl Acad Sci U S A 2022, 119: e2200230119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1505_CR55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41392-022-00872-9","volume":"7","author":"Y Jin","year":"2022","unstructured":"Jin Y, Kang Y, Wang M, Wu B, Su B, Yin H, et al. Targeting polarized phenotype of microglia via IL6\/JAK2\/STAT3 signaling to reduce NSCLC brain metastasis. Signal Transduct Target Ther 2022, 7: 52.","journal-title":"Signal Transduct Target Ther"},{"key":"1505_CR56","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/s41467-020-15267-z","volume":"11","author":"LP Bernier","year":"2020","unstructured":"Bernier LP, York EM, Kamyabi A, Choi HB, Weilinger NL, MacVicar BA. Microglial metabolic flexibility supports immune surveillance of the brain parenchyma. Nat Commun 2020, 11: 1559.","journal-title":"Nat Commun"},{"key":"1505_CR57","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41467-020-15411-9","volume":"11","author":"R Xu","year":"2020","unstructured":"Xu R, Li X, Boreland AJ, Posyton A, Kwan K, Hart RP, et al. Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain. Nat Commun 2020, 11: 1577.","journal-title":"Nat Commun"},{"key":"1505_CR58","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41593-022-01095-5","volume":"25","author":"P Kumar","year":"2022","unstructured":"Kumar P, Lim A, Hazirah SN, Chua CJH, Ngoh A, Poh SL, et al. Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling. Nat Neurosci 2022, 25: 956\u2013966.","journal-title":"Nat Neurosci"},{"key":"1505_CR59","doi-asserted-by":"crossref","unstructured":"Krukowski K, Grue K, Becker M, Elizarraras E, Frias ES, Halvorsen A, et al. The impact of deep space radiation on cognitive performance: From biological sex to biomarkers to countermeasures. Sci Adv 2021;7: eabg6702.","DOI":"10.1126\/sciadv.abg6702"},{"key":"1505_CR60","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1093\/brain\/awaa275","volume":"143","author":"M Sucksdorff","year":"2020","unstructured":"Sucksdorff M, Matilainen M, Tuisku J, Polvinen E, Vuorimaa A, Rokka J, et al. Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis. Brain 2020, 143: 3318\u20133330.","journal-title":"Brain"},{"key":"1505_CR61","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/15548627.2018.1556946","volume":"15","author":"JW Lee","year":"2019","unstructured":"Lee JW, Nam H, Kim LE, Jeon Y, Min H, Ha S, et al. TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia. Autophagy 2019, 15: 753\u2013770.","journal-title":"Autophagy"},{"key":"1505_CR62","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.3390\/ijms22094676","volume":"22","author":"K Badanjak","year":"2021","unstructured":"Badanjak K, Fixemer S, Smaji\u0107 S, Skupin A, Gr\u00fcnewald A. The contribution of microglia to neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 2021, 22: 4676.","journal-title":"Int J Mol Sci"},{"key":"1505_CR63","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-024-00717-9","volume":"19","author":"A Martirosyan","year":"2024","unstructured":"Martirosyan A, Ansari R, Pestana F, Hebestreit K, Gasparyan H, Aleksanyan R, et al. Correction: unravelling cell type-specific responses to Parkinson\u2019s disease at single cell resolution. Mol Neurodegener 2024, 19: 28.","journal-title":"Mol Neurodegener"},{"key":"1505_CR64","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 2017, 169: 1276-1290.e17.","journal-title":"Cell"},{"key":"1505_CR65","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.bbi.2025.05.027","volume":"129","author":"V Haage","year":"2025","unstructured":"Haage V, Tuddenham JF, Bautista A, Garcia GF, White CC, Patel R, et al. HDAC inhibitors engage MITF and the disease-associated microglia signature to enhance amyloid \u03b2 uptake. Brain Behav Immun 2025, 129: 279\u2013293.","journal-title":"Brain Behav Immun"},{"key":"1505_CR66","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","volume":"109","author":"SH Lee","year":"2021","unstructured":"Lee SH, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH, et al. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology. Neuron 2021, 109: 1283-1301.e6.","journal-title":"Neuron"},{"key":"1505_CR67","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuroscience.2024.07.039","volume":"555","author":"X Zhu","year":"2024","unstructured":"Zhu X, Xu Z, Liu Y, Yang J, Bai L, Li X, et al. Unveiling microglia heterogeneity in intracerebral hemorrhage. Neuroscience 2024, 555: 167\u2013177.","journal-title":"Neuroscience"},{"key":"1505_CR68","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.160940","volume":"7","author":"Z Liu","year":"2022","unstructured":"Liu Z, Shi H, Xu J, Yang Q, Ma Q, Mao X, et al. Single-cell transcriptome analyses reveal microglia types associated with proliferative retinopathy. JCI Insight 2022, 7: e160940.","journal-title":"JCI Insight"},{"key":"1505_CR69","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.immuni.2024.05.005","volume":"57","author":"KM Barclay","year":"2024","unstructured":"Barclay KM, Abduljawad N, Cheng Z, Kim MW, Zhou L, Yang J, et al. An inducible genetic tool to track and manipulate specific microglial states reveals their plasticity and roles in remyelination. Immunity 2024, 57: 1394-1412.e8.","journal-title":"Immunity"},{"key":"1505_CR70","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s41593-022-01183-6","volume":"25","author":"T Kaya","year":"2022","unstructured":"Kaya T, Mattugini N, Liu L, Ji H, Cantuti-Castelvetri L, Wu J, et al. CD8+ T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging. Nat Neurosci 2022, 25: 1446\u20131457.","journal-title":"Nat Neurosci"},{"key":"1505_CR71","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-018-0254-8","volume":"13","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju S, Dammer EB, Raza SA, Rathakrishnan P, Xiao H, Gao T, et al. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u2019s disease. Mol Neurodegener 2018, 13: 24.","journal-title":"Mol Neurodegener"},{"key":"1505_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fimmu.2020.00033","volume":"11","author":"S Sarkar","year":"2020","unstructured":"Sarkar S, Dammer EB, Malovic E, Olsen AL, Raza SA, Gao T, et al. Molecular signatures of neuroinflammation induced by \u03b1Synuclein aggregates in microglial cells. Front Immunol 2020, 11: 33.","journal-title":"Front Immunol"},{"key":"1505_CR73","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12964-024-01590-1","volume":"22","author":"P Quan","year":"2024","unstructured":"Quan P, Li X, Si Y, Sun L, Ding FF, Fan Y, et al. Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson\u2019s disease. Cell Commun Signal 2024, 22: 212.","journal-title":"Cell Commun Signal"},{"key":"1505_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13834","volume":"22","author":"YQ Yan","year":"2023","unstructured":"Yan YQ, Zheng R, Liu Y, Ruan Y, Lin ZH, Xue NJ, et al. Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson\u2019s disease. Aging Cell 2023, 22: e13834.","journal-title":"Aging Cell"},{"key":"1505_CR75","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B, et al. Microglia states and nomenclature: a field at its crossroads. Neuron 2022, 110: 3458\u20133483.","journal-title":"Neuron"},{"key":"1505_CR76","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbi.2021.06.004","volume":"96","author":"BF Osborne","year":"2021","unstructured":"Osborne BF, Beamish SB, Schwarz JM. The effects of early-life immune activation on microglia-mediated neuronal remodeling and the associated ontogeny of hippocampal-dependent learning in juvenile rats. Brain Behav Immun 2021, 96: 239\u2013255.","journal-title":"Brain Behav Immun"},{"key":"1505_CR77","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1080\/15548627.2020.1719723","volume":"16","author":"J Cheng","year":"2020","unstructured":"Cheng J, Liao Y, Dong Y, Hu H, Yang N, Kong X, et al. Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice. Autophagy 2020, 16: 2193\u20132205.","journal-title":"Autophagy"},{"key":"1505_CR78","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1111\/bph.14618","volume":"176","author":"S Nizami","year":"2019","unstructured":"Nizami S, Hall-Roberts H, Warrier S, Cowley SA, Di Daniel E. Microglial inflammation and phagocytosis in Alzheimer\u2019s disease: potential therapeutic targets. Br J Pharmacol 2019, 176: 3515\u20133532.","journal-title":"Br J Pharmacol"},{"key":"1505_CR79","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.4103\/1673-5374.385845","volume":"19","author":"T Han","year":"2024","unstructured":"Han T, Xu Y, Sun L, Hashimoto M, Wei J. Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases. Neural Regen Res 2024, 19: 1241\u20131248.","journal-title":"Neural Regen Res"},{"key":"1505_CR80","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12974-023-02723-y","volume":"20","author":"Y Xu","year":"2023","unstructured":"Xu Y, Li Y, Wang C, Han T, Liu H, Sun L, et al. The reciprocal interactions between microglia and T cells in Parkinson\u2019s disease: a double-edged sword. J Neuroinflammation 2023, 20: 33.","journal-title":"J Neuroinflammation"},{"key":"1505_CR81","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","volume":"237","author":"B Liao","year":"2012","unstructured":"Liao B, Zhao W, Beers DR, Henkel JS, Appel SH. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol 2012, 237: 147\u2013152.","journal-title":"Exp Neurol"},{"key":"1505_CR82","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","volume":"8","author":"RH Shih","year":"2015","unstructured":"Shih RH, Wang CY, Yang CM. NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci 2015, 8: 77.","journal-title":"Front Mol Neurosci"},{"key":"1505_CR83","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.neuroscience.2017.03.044","volume":"352","author":"MJ Glass","year":"2017","unstructured":"Glass MJ, Chan J, Pickel VM. Ultrastructural characterization of tumor necrosis factor alpha receptor type 1 distribution in the hypothalamic paraventricular nucleus of the mouse. Neuroscience 2017, 352: 262\u2013272.","journal-title":"Neuroscience"},{"key":"1505_CR84","doi-asserted-by":"publisher","first-page":"14753","DOI":"10.3390\/ijms232314753","volume":"23","author":"S Yi","year":"2022","unstructured":"Yi S, Wang L, Wang H, Ho MS, Zhang S. Pathogenesis of \u03b1-synuclein in Parkinson\u2019s disease: from a neuron-Glia crosstalk perspective. Int J Mol Sci 2022, 23: 14753.","journal-title":"Int J Mol Sci"},{"key":"1505_CR85","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/ejn.16136","volume":"59","author":"M Regoni","year":"2024","unstructured":"Regoni M, Valtorta F, Sassone J. Dopaminergic neuronal death via necroptosis in Parkinson\u2019s disease: a review of the literature. Eur J Neurosci 2024, 59: 1079\u20131098.","journal-title":"Eur J Neurosci"},{"key":"1505_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.619761","volume":"12","author":"D He","year":"2021","unstructured":"He D, Fu S, Zhou A, Su Y, Gao X, Zhang Y, et al. Camptothecin regulates microglia polarization and exerts neuroprotective effects via activating AKT\/Nrf2\/HO-1 and inhibiting NF-\u03baB pathways in vivo and in vitro. Front Immunol 2021, 12: 619761.","journal-title":"Front Immunol"},{"key":"1505_CR87","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fncel.2018.00324","volume":"12","author":"Z Yu","year":"2018","unstructured":"Yu Z, Yang L, Yang Y, Chen S, Sun D, Xu H, et al. Epothilone B benefits nigral dopaminergic neurons by attenuating microglia activation in the 6-hydroxydopamine lesion mouse model of Parkinson\u2019s disease. Front Cell Neurosci 2018, 12: 324.","journal-title":"Front Cell Neurosci"},{"key":"1505_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045227","volume":"7","author":"N Gresa-Arribas","year":"2012","unstructured":"Gresa-Arribas N, Vi\u00e9itez C, Dentesano G, Serratosa J, Saura J, Sol\u00e0 C. Modelling neuroinflammation in vitro: a tool to test the potential neuroprotective effect of anti-inflammatory agents. PLoS One 2012, 7: e45227.","journal-title":"PLoS One"},{"key":"1505_CR89","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13024-019-0314-8","volume":"14","author":"ME Tremblay","year":"2019","unstructured":"Tremblay ME, Cookson MR, Civiero L. Glial phagocytic clearance in Parkinson\u2019s disease. Mol Neurodegener 2019, 14: 16.","journal-title":"Mol Neurodegener"},{"key":"1505_CR90","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/cns.13619","volume":"27","author":"K Wang","year":"2021","unstructured":"Wang K, Li J, Zhang Y, Huang Y, Chen D, Shi Z, et al. Central nervous system diseases related to pathological microglial phagocytosis. CNS Neurosci Ther 2021, 27: 528\u2013539.","journal-title":"CNS Neurosci Ther"},{"key":"1505_CR91","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 2023, 8: 359.","journal-title":"Signal Transduct Target Ther"},{"key":"1505_CR92","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12964-023-01402-y","volume":"22","author":"Y Miao","year":"2024","unstructured":"Miao Y, Meng H. The involvement of \u03b1-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson\u2019s disease. Cell Commun Signal 2024, 22: 31.","journal-title":"Cell Commun Signal"},{"key":"1505_CR93","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1038\/s41467-021-26519-x","volume":"12","author":"S Bido","year":"2021","unstructured":"Bido S, Muggeo S, Massimino L, Marzi MJ, Giannelli SG, Melacini E, et al. Microglia-specific overexpression of \u03b1-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity. Nat Commun 2021, 12: 6237.","journal-title":"Nat Commun"},{"key":"1505_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202108435","volume":"34","author":"J Yuan","year":"2022","unstructured":"Yuan J, Liu H, Zhang H, Wang T, Zheng Q, Li Z. Controlled activation of TRPV1 channels on microglia to boost their autophagy for clearance of alpha-synuclein and enhance therapy of Parkinson\u2019s disease. Adv Mater 2022, 34: e2108435.","journal-title":"Adv Mater"},{"key":"1505_CR95","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1007\/s12035-022-02827-1","volume":"59","author":"L Zhang","year":"2022","unstructured":"Zhang L, Dong W, Ma Y, Bai L, Zhang X, Sun C, et al. Pon1 deficiency promotes Trem2 pathway-mediated microglial phagocytosis and inhibits pro-inflammatory cytokines release in vitro and in vivo. Mol Neurobiol 2022, 59: 4612\u20134629.","journal-title":"Mol Neurobiol"},{"key":"1505_CR96","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/jnc.16003","volume":"167","author":"F Zhang","year":"2023","unstructured":"Zhang F, Yang D, Li J, Du C, Sun X, Li W, et al. Synaptotagmin-11 regulates immune functions of microglia in vivo. J Neurochem 2023, 167: 680\u2013695.","journal-title":"J Neurochem"},{"key":"1505_CR97","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","volume":"26","author":"E Lee","year":"2019","unstructured":"Lee E, Hwang I, Park S, Hong S, Hwang B, Cho Y, et al. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ 2019, 26: 213\u2013228.","journal-title":"Cell Death Differ"},{"key":"1505_CR98","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 2023, 615: 668\u2013677.","journal-title":"Nature"},{"key":"1505_CR99","doi-asserted-by":"publisher","first-page":"1504065","DOI":"10.3389\/fnana.2025.1504065","volume":"19","author":"LK Yassin","year":"2025","unstructured":"Yassin LK, Nakhal MM, Alderei A, Almehairbi A, Mydeen AB, Akour A, et al. Exploring the microbiota-gut-brain axis: impact on brain structure and function. Front Neuroanat 2025, 19: 1504065.","journal-title":"Front Neuroanat"},{"key":"1505_CR100","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s11481-020-09926-7","volume":"15","author":"L Yang","year":"2020","unstructured":"Yang L, Mao K, Yu H, Chen J. Neuroinflammatory responses and parkinson\u2019 disease: pathogenic mechanisms and therapeutic targets. J Neuroimmune Pharmacol 2020, 15: 830\u2013837.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1505_CR101","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 2017, 541: 481\u2013487.","journal-title":"Nature"},{"key":"1505_CR102","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41531-023-00456-6","volume":"9","author":"H Pan","year":"2023","unstructured":"Pan H, Liu Z, Ma J, Li Y, Zhao Y, Zhou X, et al. Genome-wide association study using whole-genome sequencing identifies risk loci for Parkinson\u2019s disease in Chinese population. NPJ Parkinsons Dis 2023, 9: 22.","journal-title":"NPJ Parkinsons Dis"},{"key":"1505_CR103","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jamaneurol.2020.5257","volume":"78","author":"DA Kia","year":"2021","unstructured":"Kia DA, Zhang D, Guelfi S, Manzoni C, Hubbard L, Reynolds RH, et al. Identification of candidate parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets. JAMA Neurol 2021, 78: 464\u2013472.","journal-title":"JAMA Neurol"},{"key":"1505_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101648","volume":"79","author":"R Fern\u00e1ndez-Santiago","year":"2022","unstructured":"Fern\u00e1ndez-Santiago R, Sharma M. What have we learned from genome-wide association studies (GWAS) in Parkinson\u2019s disease? Ageing Res Rev 2022, 79: 101648.","journal-title":"Ageing Res Rev"},{"key":"1505_CR105","doi-asserted-by":"crossref","unstructured":"Kim JJ, Vitale D, Otani DV, Lian MM, Heilbron K, Team 2R, et al. Multi-ancestry genome-wide association meta-analysis of Parkinson\u2019s disease. Nat Genet 2024;56: 27\u201336.","DOI":"10.1038\/s41588-023-01584-8"},{"key":"1505_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-140491","volume":"5","author":"HE Allen Reish","year":"2015","unstructured":"Allen Reish HE, Standaert DG. Role of \u03b1-synuclein in inducing innate and adaptive immunity in Parkinson disease. J Parkinsons Dis 2015, 5: 1\u201319.","journal-title":"J Parkinsons Dis"},{"key":"1505_CR107","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41531-021-00210-w","volume":"7","author":"A Dagra","year":"2021","unstructured":"Dagra A, Miller DR, Lin M, Gopinath A, Shaerzadeh F, Harris S, et al. \u03b1-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability. NPJ Parkinsons Dis 2021, 7: 76.","journal-title":"NPJ Parkinsons Dis"},{"key":"1505_CR108","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 2023, 14: 176.","journal-title":"Cell Death Dis"},{"key":"1505_CR109","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/sji.12542","volume":"85","author":"Chelpin M von Euler","year":"2017","unstructured":"von Euler Chelpin M, Vorup-Jensen T. Targets and mechanisms in prevention of Parkinson\u2019s disease through immunomodulatory treatments. Scand J Immunol 2017, 85: 321\u2013330.","journal-title":"Scand J Immunol"},{"key":"1505_CR110","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12974-024-03043-5","volume":"21","author":"C Yildirim-Balatan","year":"2024","unstructured":"Yildirim-Balatan C, Fenyi A, Besnault P, Gomez L, Sepulveda-Diaz JE, Michel PP, et al. Parkinson\u2019s disease-derived \u03b1-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype. J Neuroinflammation 2024, 21: 54.","journal-title":"J Neuroinflammation"},{"key":"1505_CR111","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K, et al. Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun 2020, 11: 1386.","journal-title":"Nat Commun"},{"key":"1505_CR112","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12974-020-01940-z","volume":"17","author":"N Li","year":"2020","unstructured":"Li N, Stewart T, Sheng L, Shi M, Cilento EM, Wu Y, et al. Immunoregulation of microglial polarization: an unrecognized physiological function of \u03b1-synuclein. J Neuroinflammation 2020, 17: 272.","journal-title":"J Neuroinflammation"},{"key":"1505_CR113","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12264-022-00957-z","volume":"39","author":"R Wang","year":"2023","unstructured":"Wang R, Ren H, Kaznacheyeva E, Lu X, Wang G. Association of glial activation and \u03b1-synuclein pathology in Parkinson\u2019s disease. Neurosci Bull 2023, 39: 479\u2013490.","journal-title":"Neurosci Bull"},{"key":"1505_CR114","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s12264-024-01323-x","volume":"41","author":"Z Ma","year":"2025","unstructured":"Ma Z, Xu Y, Lian P, Wu Y, Liu K, Zhang Z, et al. Alpha-synuclein fibrils inhibit activation of the BDNF\/ERK signaling loop in the mPFC to induce Parkinson\u2019s disease-like alterations with depression. Neurosci Bull 2025, 41: 951\u2013969.","journal-title":"Neurosci Bull"},{"key":"1505_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109668","volume":"36","author":"T SenGupta","year":"2021","unstructured":"SenGupta T, Palikaras K, Esbensen YQ, Konstantinidis G, Galindo FJN, Achanta K, et al. Base excision repair causes age-dependent accumulation of single-stranded DNA breaks that contribute to Parkinson disease pathology. Cell Rep 2021, 36: 109668.","journal-title":"Cell Rep"},{"key":"1505_CR116","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","volume":"16","author":"E Tolosa","year":"2020","unstructured":"Tolosa E, Vila M, Klein C, Rascol O. LRRK2 in Parkinson disease: challenges of clinical trials. Nat Rev Neurol 2020, 16: 97\u2013107.","journal-title":"Nat Rev Neurol"},{"key":"1505_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105806","volume":"172","author":"G Tsafaras","year":"2022","unstructured":"Tsafaras G, Baekelandt V. The role of LRRK2 in the periphery: link with Parkinson\u2019s disease and inflammatory diseases. Neurobiol Dis 2022, 172: 105806.","journal-title":"Neurobiol Dis"},{"key":"1505_CR118","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.parkreldis.2022.05.012","volume":"98","author":"C Simpson","year":"2022","unstructured":"Simpson C, Vinikoor-Imler L, Nassan FL, Shirvan J, Lally C, Dam T, et al. Prevalence of ten LRRK2 variants in Parkinson\u2019s disease: a comprehensive review. Parkinsonism Relat Disord 2022, 98: 103\u2013113.","journal-title":"Parkinsonism Relat Disord"},{"key":"1505_CR119","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13101","volume":"19","author":"B Marchetti","year":"2020","unstructured":"Marchetti B, Tirolo C, L\u2019Episcopo F, Caniglia S, Testa N, Smith JA, et al. Parkinson\u2019s disease, aging and adult neurogenesis: Wnt\/\u03b2-catenin signalling as the key to unlock the mystery of endogenous brain repair. Aging Cell 2020, 19: e13101.","journal-title":"Aging Cell"},{"key":"1505_CR120","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/cdd.2012.42","volume":"19","author":"CY Chen","year":"2012","unstructured":"Chen CY, Weng YH, Chien KY, Lin KJ, Yeh TH, Cheng YP, et al. (G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD. Cell Death Differ 2012, 19: 1623\u20131633.","journal-title":"Cell Death Differ"},{"key":"1505_CR121","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1523\/JNEUROSCI.5092-10.2011","volume":"31","author":"J Dusonchet","year":"2011","unstructured":"Dusonchet J, Kochubey O, Stafa K, Young SM Jr, Zufferey R, Moore DJ, et al. A rat model of progressive nigral neurodegeneration induced by the Parkinson\u2019s disease-associated G2019S mutation in LRRK2. J Neurosci 2011, 31: 907\u2013912.","journal-title":"J Neurosci"},{"key":"1505_CR122","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13041-024-01128-z","volume":"17","author":"M Dehestani","year":"2024","unstructured":"Dehestani M, Kozareva V, Blauwendraat C, Fraenkel E, Gasser T, Bansal V. Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson\u2019s disease. Mol Brain 2024, 17: 56.","journal-title":"Mol Brain"},{"key":"1505_CR123","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/01480545.2018.1504961","volume":"43","author":"Z Elmazoglu","year":"2020","unstructured":"Elmazoglu Z, Yar Saglam AS, Sonmez C, Karasu C. Luteolin protects microglia against rotenone-induced toxicity in a hormetic manner through targeting oxidative stress response, genes associated with Parkinson\u2019s disease and inflammatory pathways. Drug Chem Toxicol 2020, 43: 96\u2013103.","journal-title":"Drug Chem Toxicol"},{"key":"1505_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001480","volume":"19","author":"A Mamais","year":"2021","unstructured":"Mamais A, Kluss JH, Bonet-Ponce L, Landeck N, Langston RG, Smith N, et al. Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia. PLoS Biol 2021, 19: e3001480.","journal-title":"PLoS Biol"},{"key":"1505_CR125","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1016\/j.cell.2021.09.007","volume":"184","author":"H Scheiblich","year":"2021","unstructured":"Scheiblich H, Dansokho C, Mercan D, Schmidt SV, Bousset L, Wischhof L, et al. Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes. Cell 2021, 184: 5089-5106.e21.","journal-title":"Cell"},{"key":"1505_CR126","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/15548627.2019.1603545","volume":"16","author":"PW Ho","year":"2020","unstructured":"Ho PW, Leung CT, Liu H, Pang SY, Lam CS, Xian J, et al. Age-dependent accumulation of oligomeric SNCA\/\u03b1-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). Autophagy 2020, 16: 347\u2013370.","journal-title":"Autophagy"},{"key":"1505_CR127","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-022-00281-6","volume":"11","author":"SY Pang","year":"2022","unstructured":"Pang SY, Lo RCN, Ho PW, Liu HF, Chang EES, Leung CT, et al. LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson\u2019s disease. Transl Neurodegener 2022, 11: 5.","journal-title":"Transl Neurodegener"},{"key":"1505_CR128","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","volume":"26","author":"DP Narendra","year":"2024","unstructured":"Narendra DP, Youle RJ. The role of PINK1-Parkin in mitochondrial quality control. Nat Cell Biol 2024, 26: 1639\u20131651.","journal-title":"Nat Cell Biol"},{"key":"1505_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101817","volume":"84","author":"J Li","year":"2023","unstructured":"Li J, Yang D, Li Z, Zhao M, Wang D, Sun Z, et al. PINK1\/Parkin-mediated mitophagy in neurodegenerative diseases. Ageing Res Rev 2023, 84: 101817.","journal-title":"Ageing Res Rev"},{"key":"1505_CR130","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","volume":"15","author":"P Ge","year":"2020","unstructured":"Ge P, Dawson VL, Dawson TM. PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease. Mol Neurodegener 2020, 15: 20.","journal-title":"Mol Neurodegener"},{"key":"1505_CR131","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/mds.29025","volume":"37","author":"K Wasner","year":"2022","unstructured":"Wasner K, Smajic S, Ghelfi J, Delcambre S, Prada-Medina CA, Knappe E, et al. Parkin deficiency impairs mitochondrial DNA dynamics and propagates inflammation. Mov Disord 2022, 37: 1405\u20131415.","journal-title":"Mov Disord"},{"key":"1505_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2023.102720","volume":"80","author":"SL Pereira","year":"2023","unstructured":"Pereira SL, Grossmann D, Delcambre S, Hermann A, Gr\u00fcnewald A. Novel insights into Parkin-mediated mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Curr Opin Neurobiol 2023, 80: 102720.","journal-title":"Curr Opin Neurobiol"},{"key":"1505_CR133","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng1769","volume":"38","author":"A Bender","year":"2006","unstructured":"Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 2006, 38: 515\u2013517.","journal-title":"Nat Genet"},{"key":"1505_CR134","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00415-008-0892-9","volume":"255","author":"A Bender","year":"2008","unstructured":"Bender A, Schwarzkopf RM, McMillan A, Krishnan KJ, Rieder G, Neumann M, et al. Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions. J Neurol 2008, 255: 1231\u20131235.","journal-title":"J Neurol"},{"key":"1505_CR135","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.nbd.2014.06.014","volume":"70","author":"LH Sanders","year":"2014","unstructured":"Sanders LH, McCoy J, Hu X, Mastroberardino PG, Dickinson BC, Chang CJ, et al. Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson\u2019s disease. Neurobiol Dis 2014, 70: 214\u2013223.","journal-title":"Neurobiol Dis"},{"key":"1505_CR136","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00018-022-04304-3","volume":"79","author":"M Lang","year":"2022","unstructured":"Lang M, Gr\u00fcnewald A, Pramstaller PP, Hicks AA, Pichler I. A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson\u2019s disease by highlighting the use of cybrid models. Cell Mol Life Sci 2022, 79: 283.","journal-title":"Cell Mol Life Sci"},{"key":"1505_CR137","first-page":"38","volume":"8","author":"C Chen","year":"2019","unstructured":"Chen C, Turnbull DM, Reeve AK. Mitochondrial dysfunction in Parkinson\u2019s disease-cause or consequence? Biology (Basel) 2019, 8: 38.","journal-title":"Biology (Basel)"},{"key":"1505_CR138","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.omtn.2023.01.003","volume":"31","author":"X Xia","year":"2023","unstructured":"Xia X, Wang Y, Zheng JC. Internal m7G methylation: a novel epitranscriptomic contributor in brain development and diseases. Mol Ther Nucleic Acids 2023, 31: 295\u2013308.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1505_CR139","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12264-024-01334-8","volume":"41","author":"Y Sun","year":"2025","unstructured":"Sun Y, Zou S, Xu X, Xu S, Sun H, Tang M, et al. Inhibition of the cGAS-STING pathway reduces cisplatin-induced inner ear hair cell damage. Neurosci Bull 2025, 41: 359\u2013373.","journal-title":"Neurosci Bull"},{"key":"1505_CR140","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.neurobiolaging.2014.01.004","volume":"35","author":"C Canugovi","year":"2014","unstructured":"Canugovi C, Shamanna RA, Croteau DL, Bohr VA. Base excision DNA repair levels in mitochondrial lysates of Alzheimer\u2019s disease. Neurobiol Aging 2014, 35: 1293\u20131300.","journal-title":"Neurobiol Aging"},{"key":"1505_CR141","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41598-017-18786-w","volume":"8","author":"L Sun","year":"2018","unstructured":"Sun L, Shen R, Agnihotri SK, Chen Y, Huang Z, B\u00fceler H. Lack of PINK1 alters Glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death. Sci Rep 2018, 8: 383.","journal-title":"Sci Rep"},{"key":"1505_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115735","volume":"168","author":"Q Huang","year":"2023","unstructured":"Huang Q, Yang P, Liu Y, Ding J, Lu M, Hu G. The interplay between \u03b1-Synuclein and NLRP3 inflammasome in Parkinson\u2019s disease. Biomed Pharmacother 2023, 168: 115735.","journal-title":"Biomed Pharmacother"},{"key":"1505_CR143","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbi.2020.09.017","volume":"91","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Kwatra M, Ranjan Panda S, Murty UN, Naidu VM. Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease. Brain Behav Immun 2021, 91: 142\u2013158.","journal-title":"Brain Behav Immun"},{"key":"1505_CR144","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1016\/j.apsb.2024.05.012","volume":"14","author":"X Zhou","year":"2024","unstructured":"Zhou X, Wang J, Yu L, Qiao G, Qin D, Yuen-Kwan Law B, et al. Mitophagy and cGAS-STING crosstalk in neuroinflammation. Acta Pharm Sin B 2024, 14: 3327\u20133361.","journal-title":"Acta Pharm Sin B"},{"key":"1505_CR145","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.2147\/JIR.S468609","volume":"17","author":"M G\u0105ssowska-Dobrowolska","year":"2024","unstructured":"G\u0105ssowska-Dobrowolska M, Olech-Kocha\u0144czyk G, Culmsee C, Adamczyk A. Novel insights into parkin-mediated mitochondrial dysfunction and \u201cmito-inflammation\u201d in \u03b1-synuclein toxicity. The role of the cGAS-STING signalling pathway. J Inflamm Res. 2024, 17: 4549\u20134574.","journal-title":"J Inflamm Res."},{"key":"1505_CR146","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2016.04.200","volume":"100","author":"F Yin","year":"2016","unstructured":"Yin F, Sancheti H, Patil I, Cadenas E. Energy metabolism and inflammation in brain aging and Alzheimer\u2019s disease. Free Radic Biol Med 2016, 100: 108\u2013122.","journal-title":"Free Radic Biol Med"},{"key":"1505_CR147","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","volume":"22","author":"R Di Micco","year":"2021","unstructured":"Di Micco R, Krizhanovsky V, Baker D, d\u2019Adda di Fagagna F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat Rev Mol Cell Biol. 2021, 22: 75\u201395.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"1505_CR148","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/s12276-024-01277-0","volume":"56","author":"W Su","year":"2024","unstructured":"Su W, Guo Y, Wang Q, Ma L, Zhang Q, Zhang Y, et al. YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis. Exp Mol Med 2024, 56: 1643\u20131654.","journal-title":"Exp Mol Med"},{"key":"1505_CR149","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41531-024-00733-y","volume":"10","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ruan L, Wang H, Zhu J, Li T, Sun G, et al. Enhancing mitochondrial proteolysis alleviates alpha-synuclein-mediated cellular toxicity. NPJ Parkinsons Dis 2024, 10: 120.","journal-title":"NPJ Parkinsons Dis"},{"key":"1505_CR150","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/jnc.13696","volume":"139","author":"D Toulorge","year":"2016","unstructured":"Toulorge D, Schapira AHV, Hajj R. Molecular changes in the postmortem parkinsonian brain. J Neurochem 2016, 139: 27\u201358.","journal-title":"J Neurochem"},{"key":"1505_CR151","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-201981","volume":"11","author":"M Borsche","year":"2021","unstructured":"Borsche M, Pereira SL, Klein C, Gr\u00fcnewald A. Mitochondria and Parkinson\u2019s disease: clinical, molecular, and translational aspects. J Parkinsons Dis 2021, 11: 45\u201360.","journal-title":"J Parkinsons Dis"},{"key":"1505_CR152","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3390\/antiox14050613","volume":"14","author":"X Liu","year":"2025","unstructured":"Liu X, Luo Q, Zhao Y, Ren P, Jin Y, Zhou J. The ferroptosis-mitochondrial axis in depression: unraveling the feedforward loop of oxidative stress, metabolic homeostasis dysregulation, and neuroinflammation. Antioxidants (Basel) 2025, 14: 613.","journal-title":"Antioxidants (Basel)"},{"key":"1505_CR153","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1002\/mds.22781","volume":"25","author":"B Thomas","year":"2010","unstructured":"Thomas B, Flint Beal M. Mitochondrial therapies for Parkinson\u2019s disease. Mov Disord 2010, 25: S155\u2013S160.","journal-title":"Mov Disord"},{"key":"1505_CR154","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-017-0032-2","volume":"3","author":"S Sarkar","year":"2017","unstructured":"Sarkar S, Malovic E, Harishchandra DS, Ghaisas S, Panicker N, Charli A, et al. Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson\u2019s disease. NPJ Parkinsons Dis 2017, 3: 30.","journal-title":"NPJ Parkinsons Dis"},{"key":"1505_CR155","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1242\/dmm.026294","volume":"10","author":"VM Pozo Devoto","year":"2017","unstructured":"Pozo Devoto VM, Falzone TL. Mitochondrial dynamics in Parkinson\u2019s disease: a role for \u03b1-synuclein? Dis Model Mech 2017, 10: 1075\u20131087.","journal-title":"Dis Model Mech"},{"key":"1505_CR156","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1042\/BCJ20190676","volume":"477","author":"U Ganguly","year":"2020","unstructured":"Ganguly U, Banerjee A, Chakrabarti SS, Kaur U, Sen O, Cappai R, et al. Interaction of \u03b1-synuclein and Parkin in iron toxicity on SH-SY5Y cells: Implications in the pathogenesis of Parkinson\u2019s disease. Biochem J 2020, 477: 1109\u20131122.","journal-title":"Biochem J"},{"key":"1505_CR157","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s43587-023-00479-x","volume":"3","author":"X Li","year":"2023","unstructured":"Li X, Li Y, Jin Y, Zhang Y, Wu J, Xu Z, et al. Transcriptional and epigenetic decoding of the microglial aging process. Nat Aging 2023, 3: 1288\u20131311.","journal-title":"Nat Aging"},{"key":"1505_CR158","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209177120","volume":"120","author":"LH Fairley","year":"2023","unstructured":"Fairley LH, Lai KO, Wong JH, Chong WJ, Vincent AS, D\u2019Agostino G, et al. Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 2023, 120: e2209177120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1505_CR159","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T. Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells 2023, 12: 1012.","journal-title":"Cells"},{"key":"1505_CR160","doi-asserted-by":"publisher","first-page":"1506358","DOI":"10.3389\/fnins.2024.1506358","volume":"18","author":"AR Trainor","year":"2024","unstructured":"Trainor AR, MacDonald DS, Penney J. Microglia: roles and genetic risk in Parkinson\u2019s disease. Front Neurosci 2024, 18: 1506358.","journal-title":"Front Neurosci"},{"key":"1505_CR161","doi-asserted-by":"publisher","first-page":"6684","DOI":"10.3390\/ijms24076684","volume":"24","author":"L Scipioni","year":"2023","unstructured":"Scipioni L, Tortolani D, Ciaramellano F, Fanti F, Gazzi T, Sergi M, et al. A\u03b2 chronic exposure promotes an activation state of microglia through endocannabinoid signalling imbalance. Int J Mol Sci 2023, 24: 6684.","journal-title":"Int J Mol Sci"},{"key":"1505_CR162","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70410","volume":"31","author":"Y Jin","year":"2025","unstructured":"Jin Y, Dong W, Jiang Y, Dong L, Li Z, Yu D. VDAC1 inhibition protects against noise-induced hearing loss via the PINK1\/parkin pathway. CNS Neurosci Ther 2025, 31: e70410.","journal-title":"CNS Neurosci Ther"},{"key":"1505_CR163","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0298095","volume":"19","author":"A Ward","year":"2024","unstructured":"Ward A, Jessop F, Faris R, Hollister J, Shoup D, Race B, et al. The PINK1\/Parkin pathway of mitophagy exerts a protective effect during prion disease. PLoS One 2024, 19: e0298095.","journal-title":"PLoS One"},{"key":"1505_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111518","volume":"126","author":"Y Yang","year":"2025","unstructured":"Yang Y, Peng Y, Li Y, Shi T, Xu N, Luan Y, et al. Sestrin2 balances mitophagy and apoptosis through the PINK1-Parkin pathway to attenuate severe acute pancreatitis. Cell Signal 2025, 126: 111518.","journal-title":"Cell Signal"},{"key":"1505_CR165","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/FJC.0000000000001625","volume":"84","author":"S Gong","year":"2024","unstructured":"Gong S, Sui Y, Xiao M, Fu D, Xiong Z, Zhang L, et al. Canagliflozin mediates mitophagy through the AMPK\/PINK1\/parkin pathway to alleviate ISO-induced cardiac remodeling. J Cardiovasc Pharmacol 2024, 84: 496\u2013505.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1505_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2025.102482","volume":"93","author":"A Bentley-DeSousa","year":"2025","unstructured":"Bentley-DeSousa A, Clegg D, Ferguson SM. LRRK2, lysosome damage, and Parkinson\u2019s disease. Curr Opin Cell Biol 2025, 93: 102482.","journal-title":"Curr Opin Cell Biol"},{"key":"1505_CR167","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00401-018-1873-4","volume":"136","author":"A Shaltouki","year":"2018","unstructured":"Shaltouki A, Hsieh CH, Kim MJ, Wang X. Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson\u2019s models. Acta Neuropathol 2018, 136: 607\u2013620.","journal-title":"Acta Neuropathol"},{"key":"1505_CR168","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/cvr\/cvae238","volume":"121","author":"H Zhou","year":"2025","unstructured":"Zhou H, Wang X, Xu T, Gan D, Ma Z, Zhang H, et al. PINK1-mediated mitophagy attenuates pathological cardiac hypertrophy by suppressing the mtDNA release-activated cGAS-STING pathway. Cardiovasc Res 2025, 121: 128\u2013142.","journal-title":"Cardiovasc Res"},{"key":"1505_CR169","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.3390\/cancers13164027","volume":"13","author":"A Abdrakhmanov","year":"2021","unstructured":"Abdrakhmanov A, Yapryntseva MA, Kaminskyy VO, Zhivotovsky B, Gogvadze V. Receptor-mediated mitophagy rescues cancer cells under hypoxic conditions. Cancers (Basel) 2021, 13: 4027.","journal-title":"Cancers (Basel)"},{"key":"1505_CR170","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/cr.2014.75","volume":"24","author":"L Liu","year":"2014","unstructured":"Liu L, Sakakibara K, Chen Q, Okamoto K. Receptor-mediated mitophagy in yeast and mammalian systems. Cell Res 2014, 24: 787\u2013795.","journal-title":"Cell Res"},{"key":"1505_CR171","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202204021","volume":"222","author":"MO Gok","year":"2023","unstructured":"Gok MO, Connor OM, Wang X, Menezes CJ, Llamas CB, Mishra P, et al. The outer mitochondrial membrane protein TMEM11 demarcates spatially restricted BNIP3\/BNIP3L-mediated mitophagy. J Cell Biol 2023, 222: e202204021.","journal-title":"J Cell Biol"},{"key":"1505_CR172","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41586-018-0448-9","volume":"561","author":"DA Sliter","year":"2018","unstructured":"Sliter DA, Martinez J, Hao L, Chen X, Sun N, Fischer TD, et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature 2018, 561: 258\u2013262.","journal-title":"Nature"},{"key":"1505_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.896014","volume":"10","author":"C Li","year":"2022","unstructured":"Li C, Pan Y, Tan Y, Wang Y, Sun X. PINK1-dependent mitophagy reduced endothelial hyperpermeability and cell migration capacity under simulated microgravity. Front Cell Dev Biol 2022, 10: 896014.","journal-title":"Front Cell Dev Biol"},{"key":"1505_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156580","volume":"140","author":"X Tang","year":"2025","unstructured":"Tang X, Huang L, Ma W, Huang M, Zeng Z, Yu Y, et al. Intestinal 8 gingerol attenuates TBI-induced neuroinflammation by inhibiting microglia NLRP3 inflammasome activation in a PINK1\/Parkin-dependent manner. Phytomedicine 2025, 140: 156580.","journal-title":"Phytomedicine"},{"key":"1505_CR175","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2021.02.019","volume":"166","author":"J Zhang","year":"2021","unstructured":"Zhang J, Huang W, He Q, Deng T, Wu B, Huang F, et al. PINK1\/PARK2 dependent mitophagy effectively suppresses NLRP3 inflammasome to alleviate acute pancreatitis. Free Radic Biol Med 2021, 166: 147\u2013164.","journal-title":"Free Radic Biol Med"},{"key":"1505_CR176","doi-asserted-by":"publisher","first-page":"9341018","DOI":"10.1155\/2019\/9341018","volume":"2019","author":"R Li","year":"2019","unstructured":"Li R, Chen J. Salidroside protects dopaminergic neurons by enhancing PINK1\/parkin-mediated mitophagy. Oxid Med Cell Longev 2019, 2019: 9341018.","journal-title":"Oxid Med Cell Longev"},{"key":"1505_CR177","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1080\/15548627.2024.2318077","volume":"20","author":"P Kulkarni","year":"2024","unstructured":"Kulkarni P, Nguyen-Dien GT, Kozul KL, Pagan JK. FBXL4: Safeguarding against mitochondrial depletion through suppression of mitophagy. Autophagy 2024, 20: 1459\u20131461.","journal-title":"Autophagy"},{"key":"1505_CR178","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1093\/hmg\/ddad102","volume":"32","author":"MG Williamson","year":"2023","unstructured":"Williamson MG, Madureira M, McGuinness W, Heon-Roberts R, Mock ED, Naidoo K, et al. Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson\u2019s disease models. Hum Mol Genet 2023, 32: 2808\u20132821.","journal-title":"Hum Mol Genet"},{"key":"1505_CR179","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41419-023-06251-8","volume":"14","author":"O Lurette","year":"2023","unstructured":"Lurette O, Mart\u00edn-Jim\u00e9nez R, Khan M, Sheta R, Jean S, Schofield M, et al. Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization. Cell Death Dis 2023, 14: 729.","journal-title":"Cell Death Dis"},{"key":"1505_CR180","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/biom11101508","volume":"11","author":"A Picca","year":"2021","unstructured":"Picca A, Guerra F, Calvani R, Romano R, Coelho-J\u00fanior HJ, Bucci C, et al. Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson\u2019s disease: roads to biomarker discovery. Biomolecules 2021, 11: 1508.","journal-title":"Biomolecules"},{"key":"1505_CR181","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.tcb.2024.01.010","volume":"34","author":"J Jacquemyn","year":"2024","unstructured":"Jacquemyn J, Ralhan I, Ioannou MS. Driving factors of neuronal ferroptosis. Trends Cell Biol 2024, 34: 535\u2013546.","journal-title":"Trends Cell Biol"},{"key":"1505_CR182","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41419-020-2402-7","volume":"11","author":"DG Lee","year":"2020","unstructured":"Lee DG, Kam MK, Lee SR, Lee HJ, Lee DS. Peroxiredoxin 5 deficiency exacerbates iron overload-induced neuronal death via ER-mediated mitochondrial fission in mouse hippocampus. Cell Death Dis 2020, 11: 204.","journal-title":"Cell Death Dis"},{"key":"1505_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105122","volume":"161","author":"W Chen","year":"2020","unstructured":"Chen W, Guo C, Huang S, Jia Z, Wang J, Zhong J, et al. MitoQ attenuates brain damage by polarizing microglia towards the M2 phenotype through inhibition of the NLRP3 inflammasome after ICH. Pharmacol Res 2020, 161: 105122.","journal-title":"Pharmacol Res"},{"key":"1505_CR184","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/1673-5374.286954","volume":"16","author":"W Zhang","year":"2021","unstructured":"Zhang W, Tian T, Gong SX, Huang WQ, Zhou QY, Wang AP, et al. Microglia-associated neuroinflammation is a potential therapeutic target for ischemic stroke. Neural Regen Res 2021, 16: 6\u201311.","journal-title":"Neural Regen Res"},{"key":"1505_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113686","volume":"156","author":"G Cao","year":"2022","unstructured":"Cao G, Gong T, Du Y, Wang Y, Ge T, Liu J. Mechanism of metformin regulation in central nervous system: progression and future perspectives. Biomed Pharmacother 2022, 156: 113686.","journal-title":"Biomed Pharmacother"},{"key":"1505_CR186","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1007\/s11095-024-03777-0","volume":"41","author":"C Cai","year":"2024","unstructured":"Cai C, Gu C, Meng C, He S, Thashi L, Deji D, et al. Therapeutic effects of metformin on central nervous system diseases: a focus on protection of neurovascular unit. Pharm Res 2024, 41: 1907\u20131920.","journal-title":"Pharm Res"},{"key":"1505_CR187","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/antiox9100943","volume":"9","author":"H Ismail","year":"2020","unstructured":"Ismail H, Shakkour Z, Tabet M, Abdelhady S, Kobaisi A, Abedi R, et al. Traumatic brain injury: oxidative stress and novel anti-oxidants such as mitoquinone and edaravone. Antioxidants (Basel) 2020, 9: 943.","journal-title":"Antioxidants (Basel)"},{"key":"1505_CR188","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/mds.23148","volume":"25","author":"BJ Snow","year":"2010","unstructured":"Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O\u2019Sullivan JD, Fung V, et al. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson\u2019s disease. Mov Disord 2010, 25: 1670\u20131674.","journal-title":"Mov Disord"},{"key":"1505_CR189","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.3390\/ijms21176192","volume":"21","author":"D M\u00e9ndez","year":"2020","unstructured":"M\u00e9ndez D, Arauna D, Fuentes F, Araya-Maturana R, Palomo I, Alarc\u00f3n M, et al. Mitoquinone (MitoQ) inhibits platelet activation steps by reducing ROS levels. Int J Mol Sci 2020, 21: 6192.","journal-title":"Int J Mol Sci"},{"key":"1505_CR190","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-981-13-9913-8_13","volume":"1175","author":"MS Ho","year":"2019","unstructured":"Ho MS. Microglia in Parkinson\u2019s disease. Adv Exp Med Biol 2019, 1175: 335\u2013353.","journal-title":"Adv Exp Med Biol"},{"key":"1505_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2019.103409","volume":"101","author":"ML Young","year":"2019","unstructured":"Young ML, Franklin JL. The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice. Mol Cell Neurosci 2019, 101: 103409.","journal-title":"Mol Cell Neurosci"},{"key":"1505_CR192","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrd.2017.170","volume":"16","author":"AL Mora","year":"2017","unstructured":"Mora AL, Rojas M, Pardo A, Selman M. Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease. Nat Rev Drug Discov 2017, 16: 755\u2013772.","journal-title":"Nat Rev Drug Discov"},{"key":"1505_CR193","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409329","volume":"36","author":"L Lei","year":"2024","unstructured":"Lei L, Yuan J, Dai Z, Xiang S, Tu Q, Cui X, et al. Targeting the labile iron pool with engineered DFO nanosheets to inhibit ferroptosis for Parkinson\u2019s disease therapy. Adv Mater 2024, 36: e2409329.","journal-title":"Adv Mater"},{"key":"1505_CR194","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2174\/1570159X13666151030102718","volume":"14","author":"R Filograna","year":"2016","unstructured":"Filograna R, Beltramini M, Bubacco L, Bisaglia M. Anti-oxidants in Parkinson\u2019s disease therapy: a critical point of view. Curr Neuropharmacol 2016, 14: 260\u2013271.","journal-title":"Curr Neuropharmacol"},{"key":"1505_CR195","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3390\/biomedicines12081737","volume":"12","author":"B Ana","year":"2024","unstructured":"Ana B. Aged-related changes in microglia and neurodegenerative diseases: exploring the connection. Biomedicines 2024, 12: 1737.","journal-title":"Biomedicines"},{"key":"1505_CR196","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/glia.23925","volume":"69","author":"X Zhang","year":"2021","unstructured":"Zhang X, Heng Y, Kooistra SM, van Weering HRJ, Brummer ML, Gerrits E, et al. Intrinsic DNA damage repair deficiency results in progressive microglia loss and replacement. Glia 2021, 69: 729\u2013745.","journal-title":"Glia"},{"key":"1505_CR197","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s44321-024-00046-w","volume":"16","author":"J Xie","year":"2024","unstructured":"Xie J, Cheng J, Ko H, Tang Y. Cytosolic DNA sensors in neurodegenerative diseases: from physiological defenders to pathological culprits. EMBO Mol Med 2024, 16: 678\u2013699.","journal-title":"EMBO Mol Med"},{"key":"1505_CR198","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-024-02835-6","volume":"148","author":"N Roy","year":"2024","unstructured":"Roy N, Haq I, Ngo JC, Bennett DA, Teich AF, De Jager PL, et al. Elevated expression of the retrotransposon LINE-1 drives Alzheimer\u2019s disease-associated microglial dysfunction. Acta Neuropathol 2024, 148: 75.","journal-title":"Acta Neuropathol"},{"key":"1505_CR199","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41577-022-00751-y","volume":"23","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Simon M, Seluanov A, Gorbunova V. DNA damage and repair in age-related inflammation. Nat Rev Immunol 2023, 23: 75\u201389.","journal-title":"Nat Rev Immunol"},{"key":"1505_CR200","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2024.103634","volume":"135","author":"NL Maliar","year":"2024","unstructured":"Maliar NL, Talbot EJ, Edwards AR, Khoronenkova SV. Microglial inflammation in genome instability: a neurodegenerative perspective. DNA Repair 2024, 135: 103634.","journal-title":"DNA Repair"},{"key":"1505_CR201","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-024-02044-3","volume":"10","author":"H Wen","year":"2025","unstructured":"Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X, et al. Mitochondrial diseases: from molecular mechanisms to therapeutic advances. Signal Transduct Target Ther 2025, 10: 9.","journal-title":"Signal Transduct Target Ther"},{"key":"1505_CR202","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.cell.2024.04.037","volume":"187","author":"A Suomalainen","year":"2024","unstructured":"Suomalainen A, Nunnari J. Mitochondria at the crossroads of health and disease. Cell 2024, 187: 2601\u20132627.","journal-title":"Cell"},{"key":"1505_CR203","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/ars.2018.7606","volume":"31","author":"Y Kim","year":"2019","unstructured":"Kim Y, Vadodaria KC, Lenkei Z, Kato T, Gage FH, Marchetto MC, et al. Mitochondria, metabolism, and redox mechanisms in psychiatric disorders. Antioxid Redox Signal 2019, 31: 275\u2013317.","journal-title":"Antioxid Redox Signal"},{"key":"1505_CR204","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1152\/physrev.00025.2007","volume":"88","author":"RC Scarpulla","year":"2008","unstructured":"Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008, 88: 611\u2013638.","journal-title":"Physiol Rev"},{"key":"1505_CR205","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/j.1471-4159.2009.06189.x","volume":"110","author":"L Marinova-Mutafchieva","year":"2009","unstructured":"Marinova-Mutafchieva L, Sadeghian M, Broom L, Davis JB, Medhurst AD, Dexter DT. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson\u2019s disease. J Neurochem 2009, 110: 966\u2013975.","journal-title":"J Neurochem"},{"key":"1505_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113707","volume":"341","author":"MJ Beckstead","year":"2021","unstructured":"Beckstead MJ, Howell RD. Progressive Parkinsonism due to mitochondrial impairment: lessons from the MitoPark mouse model. Exp Neurol 2021, 341: 113707.","journal-title":"Exp Neurol"},{"key":"1505_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103815","volume":"76","author":"A Valiente-Pallej\u00e0","year":"2022","unstructured":"Valiente-Pallej\u00e0 A, Tortajada J, Bulduk BK, Vilella E, Garrabou G, Muntan\u00e9 G, et al. Comprehensive summary of mitochondrial DNA alterations in the postmortem human brain: a systematic review. EBioMedicine 2022, 76: 103815.","journal-title":"EBioMedicine"},{"key":"1505_CR208","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s10571-022-01265-w","volume":"43","author":"M Abrishamdar","year":"2023","unstructured":"Abrishamdar M, Jalali MS, Farbood Y. Targeting mitochondria as a therapeutic approach for Parkinson\u2019s disease. Cell Mol Neurobiol 2023, 43: 1499\u20131518.","journal-title":"Cell Mol Neurobiol"},{"key":"1505_CR209","doi-asserted-by":"publisher","first-page":"7952","DOI":"10.3390\/ijms25147952","volume":"25","author":"EH Choi","year":"2024","unstructured":"Choi EH, Kim MH, Park SJ. Targeting mitochondrial dysfunction and reactive oxygen species for neurodegenerative disease treatment. Int J Mol Sci 2024, 25: 7952.","journal-title":"Int J Mol Sci"},{"key":"1505_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117084","volume":"178","author":"S Chen","year":"2024","unstructured":"Chen S, Li Q, Shi H, Li F, Duan Y, Guo Q. New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases. Biomed Pharmacother 2024, 178: 117084.","journal-title":"Biomed Pharmacother"},{"key":"1505_CR211","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/antiox9111056","volume":"9","author":"D Lee","year":"2020","unstructured":"Lee D, Jo MG, Kim SY, Chung CG, Lee SB. Dietary antioxidants and the mitochondrial quality control: their potential roles in Parkinson\u2019s disease treatment. Antioxidants (Basel) 2020, 9: 1056.","journal-title":"Antioxidants (Basel)"},{"key":"1505_CR212","doi-asserted-by":"crossref","unstructured":"Sharma R, Bhate L, Agrawal Y, Aspatwar A. Advanced nutraceutical approaches to Parkinson\u2019s disease: Bridging nutrition and neuroprotection. Nutr Neurosci 2025: 1\u201317.","DOI":"10.1080\/1028415X.2025.2469170"},{"key":"1505_CR213","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/antiox13050606","volume":"13","author":"MI Prasanth","year":"2024","unstructured":"Prasanth MI, Sivamaruthi BS, Cheong CSY, Verma K, Tencomnao T, Brimson JM, et al. Role of epigenetic modulation in neurodegenerative diseases: Implications of phytochemical interventions. Antioxidants (Basel) 2024, 13: 606.","journal-title":"Antioxidants (Basel)"},{"key":"1505_CR214","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","volume":"7","author":"J Guo","year":"2022","unstructured":"Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther 2022, 7: 391.","journal-title":"Signal Transduct Target Ther"},{"key":"1505_CR215","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00018-022-04536-3","volume":"79","author":"C Li","year":"2022","unstructured":"Li C, Ren J, Zhang M, Wang H, Yi F, Wu J, et al. The heterogeneity of microglial activation and its epigenetic and non-coding RNA regulations in the immunopathogenesis of neurodegenerative diseases. Cell Mol Life Sci 2022, 79: 511.","journal-title":"Cell Mol Life Sci"},{"key":"1505_CR216","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","volume":"7","author":"QJ Wu","year":"2022","unstructured":"Wu QJ, Zhang TN, Chen HH, Yu XF, Lv JL, Liu YY, et al. The sirtuin family in health and disease. Signal Transduct Target Ther 2022, 7: 402.","journal-title":"Signal Transduct Target Ther"},{"key":"1505_CR217","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/cancers17020257","volume":"17","author":"M Iskandar","year":"2025","unstructured":"Iskandar M, Xiao Barbero M, Jaber M, Chen R, Gomez-Guevara R, Cruz E, et al. A review of telomere attrition in cancer and aging: current molecular insights and future therapeutic approaches. Cancers (Basel) 2025, 17: 257.","journal-title":"Cancers (Basel)"},{"key":"1505_CR218","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1474-4422(11)70013-8","volume":"10","author":"DJ Bonda","year":"2011","unstructured":"Bonda DJ, Lee HG, Camins A, Pall\u00e0s M, Casadesus G, Smith MA, et al. The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol 2011, 10: 275\u2013279.","journal-title":"Lancet Neurol"},{"key":"1505_CR219","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.3390\/ijms22094654","volume":"22","author":"BS Basavarajappa","year":"2021","unstructured":"Basavarajappa BS, Subbanna S. Histone methylation regulation in neurodegenerative disorders. Int J Mol Sci 2021, 22: 4654.","journal-title":"Int J Mol Sci"},{"key":"1505_CR220","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41593-020-00773-6","volume":"24","author":"P Mastorakos","year":"2021","unstructured":"Mastorakos P, Mihelson N, Luby M, Burks SR, Johnson K, Hsia AW, et al. Temporally distinct myeloid cell responses mediate damage and repair after cerebrovascular injury. Nat Neurosci 2021, 24: 245\u2013258.","journal-title":"Nat Neurosci"},{"key":"1505_CR221","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41467-019-13896-7","volume":"11","author":"SI Ahn","year":"2020","unstructured":"Ahn SI, Sei YJ, Park HJ, Kim J, Ryu Y, Choi JJ, et al. Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms. Nat Commun 2020, 11: 175.","journal-title":"Nat Commun"},{"key":"1505_CR222","doi-asserted-by":"publisher","first-page":"1900962","DOI":"10.1002\/advs.201900962","volume":"6","author":"Y Shin","year":"2019","unstructured":"Shin Y, Choi SH, Kim E, Bylykbashi E, Kim JA, Chung S, et al. Blood-brain barrier dysfunction in a 3D in vitro model of Alzheimer\u2019s disease. Adv Sci (Weinh) 2019, 6: 1900962.","journal-title":"Adv Sci (Weinh)"},{"key":"1505_CR223","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s43587-021-00043-5","volume":"1","author":"WA Banks","year":"2021","unstructured":"Banks WA, Reed MJ, Logsdon AF, Rhea EM, Erickson MA. Healthy aging and the blood-brain barrier. Nat Aging 2021, 1: 243\u2013254.","journal-title":"Nat Aging"},{"key":"1505_CR224","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1177\/0271678X17726062","volume":"38","author":"J Zhu","year":"2018","unstructured":"Zhu J, Li X, Yin J, Hu Y, Gu Y, Pan S. Glycocalyx degradation leads to blood-brain barrier dysfunction and brain edema after asphyxia cardiac arrest in rats. J Cereb Blood Flow Metab 2018, 38: 1979\u20131992.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1505_CR225","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41593-020-00793-2","volume":"24","author":"DA Hartmann","year":"2021","unstructured":"Hartmann DA, Berthiaume AA, Grant RI, Harrill SA, Koski T, Tieu T, et al. Brain capillary pericytes exert a substantial but slow influence on blood flow. Nat Neurosci 2021, 24: 633\u2013645.","journal-title":"Nat Neurosci"},{"key":"1505_CR226","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","volume":"18","author":"I Galea","year":"2021","unstructured":"Galea I. The blood-brain barrier in systemic infection and inflammation. Cell Mol Immunol 2021, 18: 2489\u20132501.","journal-title":"Cell Mol Immunol"},{"key":"1505_CR227","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1093\/brain\/awab478","volume":"145","author":"RJ Jackson","year":"2022","unstructured":"Jackson RJ, Meltzer JC, Nguyen H, Commins C, Bennett RE, Hudry E, et al. APOE4 derived from astrocytes leads to blood-brain barrier impairment. Brain 2022, 145: 3582\u20133593.","journal-title":"Brain"},{"key":"1505_CR228","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1093\/eurheartj\/ehaa207","volume":"41","author":"B Liao","year":"2020","unstructured":"Liao B, Geng L, Zhang F, Shu L, Wei L, Yeung PKK, et al. Adipocyte fatty acid-binding protein exacerbates cerebral ischaemia injury by disrupting the blood-brain barrier. Eur Heart J 2020, 41: 3169\u20133180.","journal-title":"Eur Heart J"},{"key":"1505_CR229","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","volume":"13","author":"K Lau","year":"2024","unstructured":"Lau K, Kotzur R, Richter F. Blood-brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy. Transl Neurodegener 2024, 13: 37.","journal-title":"Transl Neurodegener"},{"key":"1505_CR230","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","volume":"10","author":"K Haruwaka","year":"2019","unstructured":"Haruwaka K, Ikegami A, Tachibana Y, Ohno N, Konishi H, Hashimoto A, et al. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun 2019, 10: 5816.","journal-title":"Nat Commun"},{"key":"1505_CR231","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.molmed.2019.11.006","volume":"26","author":"JD Laman","year":"2020","unstructured":"Laman JD, Power C, Dziarski R. Bacterial peptidoglycan as a driver of chronic brain inflammation. Trends Mol Med 2020, 26: 670\u2013682.","journal-title":"Trends Mol Med"},{"key":"1505_CR232","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol 2014, 14: 463\u2013477.","journal-title":"Nat Rev Immunol"},{"key":"1505_CR233","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/brain\/awy082","volume":"141","author":"NJ Lee","year":"2018","unstructured":"Lee NJ, Ha SK, Sati P, Absinta M, Luciano NJ, Lefeuvre JA, et al. Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination. Brain 2018, 141: 1637\u20131649.","journal-title":"Brain"},{"key":"1505_CR234","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.immuni.2021.09.014","volume":"54","author":"K Borst","year":"2021","unstructured":"Borst K, Dumas AA, Prinz M. Microglia: immune and non-immune functions. Immunity 2021, 54: 2194\u20132208.","journal-title":"Immunity"},{"key":"1505_CR235","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smaji\u0107","year":"2022","unstructured":"Smaji\u0107 S, Prada-Medina CA, Landoulsi Z, Ghelfi J, Delcambre S, Dietrich C, et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain 2022, 145: 964\u2013978.","journal-title":"Brain"},{"key":"1505_CR236","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kam TI, Panicker N, Kim S, Oh Y, Park JS, et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat Med 2018, 24: 931\u2013938.","journal-title":"Nat Med"},{"key":"1505_CR237","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 2016, 352: 712\u2013716.","journal-title":"Science"},{"key":"1505_CR238","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, et al. Immunosenescence: Molecular mechanisms and diseases. Signal Transduct Target Ther 2023, 8: 200.","journal-title":"Signal Transduct Target Ther"},{"key":"1505_CR239","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-024-00402-3","volume":"13","author":"C Rim","year":"2024","unstructured":"Rim C, You MJ, Nahm M, Kwon MS. Emerging role of senescent microglia in brain aging-related neurodegenerative diseases. Transl Neurodegener 2024, 13: 10.","journal-title":"Transl Neurodegener"},{"key":"1505_CR240","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1126\/science.adi3450","volume":"384","author":"JR Herdy","year":"2024","unstructured":"Herdy JR, Mertens J, Gage FH. Neuronal senescence may drive brain aging. Science 2024, 384: 1404\u20131406.","journal-title":"Science"},{"key":"1505_CR241","doi-asserted-by":"publisher","first-page":"102141","DOI":"10.1016\/j.arr.2023.102141","volume":"93","author":"LS Melo Dos Santos","year":"2024","unstructured":"Melo Dos Santos LS, Trombetta-Lima M, Eggen B, Demaria M. Cellular senescence in brain aging and neurodegeneration. Ageing Res Rev. 2024, 93: 102141.","journal-title":"Ageing Res Rev."},{"key":"1505_CR242","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-024-00397-x","volume":"13","author":"Y Liu","year":"2024","unstructured":"Liu Y, Tan Y, Zhang Z, Yi M, Zhu L, Peng W. The interaction between ageing and Alzheimer\u2019s disease: insights from the hallmarks of ageing. Transl Neurodegener 2024, 13: 7.","journal-title":"Transl Neurodegener"},{"key":"1505_CR243","first-page":"24","volume":"2023","author":"FL Andronie-Cioara","year":"1869","unstructured":"Andronie-Cioara FL, Ardelean AI, Nistor-Cseppento CD, Jurcau A, Jurcau MC, Pascalau N, et al. Molecular mechanisms of neuroinflammation in aging and Alzheimer\u2019s disease progression. Int J Mol Sci 1869, 2023: 24.","journal-title":"Int J Mol Sci"},{"key":"1505_CR244","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40035-024-00457-2","volume":"13","author":"Z Huang","year":"2024","unstructured":"Huang Z, Xu P, Hess DC, Zhang Q. Cellular senescence as a key contributor to secondary neurodegeneration in traumatic brain injury and stroke. Transl Neurodegener 2024, 13: 61.","journal-title":"Transl Neurodegener"},{"key":"1505_CR245","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40035-024-00447-4","volume":"13","author":"J Zhu","year":"2024","unstructured":"Zhu J, Wu C, Yang L. Cellular senescence in Alzheimer\u2019s disease: from physiology to pathology. Transl Neurodegener 2024, 13: 55.","journal-title":"Transl Neurodegener"},{"key":"1505_CR246","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109334","volume":"36","author":"D Paramos-de-Carvalho","year":"2021","unstructured":"Paramos-de-Carvalho D, Martins I, Crist\u00f3v\u00e3o AM, Dias AF, Neves-Silva D, Pereira T, et al. Targeting senescent cells improves functional recovery after spinal cord injury. Cell Rep 2021, 36: 109334.","journal-title":"Cell Rep"},{"key":"1505_CR247","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/febs.16315","volume":"290","author":"PY Ng","year":"2023","unstructured":"Ng PY, McNeely TL, Baker DJ. Untangling senescent and damage-associated microglia in the aging and diseased brain. FEBS J 2023, 290: 1326\u20131339.","journal-title":"FEBS J"},{"key":"1505_CR248","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen MF, Samson N, Keller A, Schwabenland M, Liu C, Gl\u00fcck S, et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 2023, 620: 374\u2013380.","journal-title":"Nature"},{"key":"1505_CR249","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.tcb.2018.04.006","volume":"28","author":"CJ Sieben","year":"2018","unstructured":"Sieben CJ, Sturmlechner I, van de Sluis B, van Deursen JM. Two-step senescence-focused cancer therapies. Trends Cell Biol 2018, 28: 723\u2013737.","journal-title":"Trends Cell Biol"},{"key":"1505_CR250","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrd.2017.116","volume":"16","author":"BG Childs","year":"2017","unstructured":"Childs BG, Gluscevic M, Baker DJ, Laberge RM, Marquess D, Dananberg J, et al. Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov 2017, 16: 718\u2013735.","journal-title":"Nat Rev Drug Discov"},{"key":"1505_CR251","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2021.644319","volume":"3","author":"V Meneghini","year":"2021","unstructured":"Meneghini V, Peviani M, Luciani M, Zambonini G, Gritti A. Delivery platforms for CRISPR\/Cas9 genome editing of glial cells in the central nervous system. Front Genome Ed 2021, 3: 644319.","journal-title":"Front Genome Ed"},{"key":"1505_CR252","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.596976","volume":"15","author":"CSB Singh","year":"2021","unstructured":"Singh CSB, Eyford BA, Abraham T, Munro L, Choi KB, Okon M, et al. Discovery of a highly conserved peptide in the iron transporter melanotransferrin that traverses an intact blood brain barrier and localizes in neural cells. Front Neurosci 2021, 15: 596976.","journal-title":"Front Neurosci"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01505-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-025-01505-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01505-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:03:33Z","timestamp":1770278613000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-025-01505-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":252,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1007\/s12264-025-01505-1","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}